Authors

Latest:

Kathryn Ciccolini Discusses the CREAM Principles to Manage Dermatologic AEs

Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the concept she developed to manage dermatologic adverse events for patients with cancer.

Kathryn E. Beckermann, MD, PhD

Kathryn E. Beckermann, MD, PhD, is an assistant professor in the Department of Medicine of the Division of Hematology and Oncology at the Vanderbilt School of Medicine in Nashville, Tennessee.

Latest:

Rounding Up Relevant Data in RCC With Drs Beckermann and Rini

Brian I. Rini, MD, FASCO, and Katy Beckermann, MD, PhD, sit down with Chandler Park, MD, FACP, to discuss the latest abstracts in renal cell carcinoma presented during the 2025 ESMO Congress.

Kathryn E. Hudson, MD

Latest:

Dr. Hudson on the Utility of Liquid Biopsy in Lung Cancer

Kathryn E. Hudson, MD, discusses the utility of liquid biopsy in lung cancer.

Kathryn Kolibaba, MD

Latest:

Dr. Kolibaba on Efficacy of Entospletinib in Mantle Cell Lymphoma

Kathryn Kolibaba, MD, co-chair, Hematology Research Committee, US Oncology Research, discusses why the Syk inhibitor entospletinib demonstrates efficacy in patients with mantle cell lymphoma (MCL).

Kathryn Mileham, MD

Latest:

Dr. Mileham Discusses Biomarkers in Lung Cancer

Kathryn Mileham, MD, medical oncologist, Levine Cancer Institute, Carolinas HealthCare System, discusses biomarkers in lung cancer.

Kathryn Ruddy, MD

Latest:

Dr. Ruddy on the Use of GnRH Agonists in Breast Cancer

Kathryn Ruddy, MD, discusses the use of GnRH agonists in breast cancer.

Kathy Boltz, PhD

Latest:

Nivolumab/Radiotherapy Combo Well-Tolerated in Newly Diagnosed GBM

Treatment with nivolumab and radiotherapy with or without concurrent temozolomide was well tolerated and showed promising signs of efficacy for patients with newly-diagnosed glioblastoma multiforme.

Kathy J. Schilling, MD

Latest:

Dr. Schilling on Dense Breast Tissue Detection Methods

Kathy J. Schilling, MD, a radiologist at Boca Raton Regional Hospital, discusses the importance of additional screening for women with dense breasts.

Kathy S. Albain, MD

Latest:

Dr. Albain Discusses Race-Based Breast Cancer Study Within TAILORx

Kathy S. Albain, MD, director, Breast Clinical Research Program, co-director, Breast Oncology Center, professor of medicine, Stritch School of Medicine, Loyola University Chicago, discusses a race-based study within the TAILORx trial.

Kathy W. Oubre, MS

Latest:

It Takes a Village, Not a Navigator

Pontchartrain Cancer Center was faced with the same dilemma most community-based independents have dealt with: reinvent the practice or join a hospital.

Katie Eder

Latest:

Cancer-Related Pain Fraught With Therapeutic and Ethical Complexities

As long-term cancer survival rates continue to surge, an increasing percentage of patients with cancer-related pain are progressing to the chronic pain arena, which necessitates more contemporary treatment approaches to cancer pain management.

Katie Hay

Latest:

Adapt Healthcare Skills to Meet Cancer Needs of LGBT Community

Cancer doesnâ€™t discriminate, but that doesnâ€™t mean the healthcare system wonâ€™t. This proves to be even more true for the lesbian, gay, bisexual and transgender community.

Katie Kelley, MD, Hellen Diller Family Comprehensive Cancer Center

Latest:

Hepatocellular Carcinoma: A Rapidly Evolving Treatment Landscape

Discussion around topics pertaining to the use of systemic therapy in advanced liver cancer. Topics will include the latest research in the field and the impact of recent clinical trials on making decisions around treatment selection.

Katie Kerrigan, DO

Latest:

Incorporating PROs Can Improve Patient Care and Outcomes in Oncology

Karnofsky Performance Status and ECOG performance status alone leaves a lot to be desired for the practicing oncologist.

Katie Kerrigan, MD

Latest:

Dr. Kerrigan on Sequencing Challenges in ALK+ NSCLC

Katie Kerrigan, MD, discusses sequencing challenges in the treatment of patients with ALK-positive non–small cell lung cancer.

Katie Kosko

Latest:

Immunotherapy Combinations Deliver Outcome-Shifting Responses in Lymphoma

Immunotherapy has become a valuable tool for the treatment of patients with various types of lymphomas because of its ability to specifically target cancer cells, particularly those in blood cancers.

Katie Kosko & Tony Hagen

Latest:

Cures Act Moves Step Closer to Adoption With Senate Approval

The sweeping, $6.3 billion 21st Century Cures Act, designed to create a 10-year pool of money for precision medicine development and social health initiatives, gained overwhelming Senate approval Wednesday and goes next to President Obama, who has said he will sign the bill.

Katie Moore, MD, University of Oklahoma

Katina Robison, MD

Latest:

Moving Beyond Standard of Care: Novel Treatments in Gynecologic Cancer

In the United States, gynecologic cancers affect nearly 80,000 women annually and are the cause of death in more than 25,000 women.

Katja Weisel, MD

Latest:

Unmet Needs in the Management of Multiple Myeloma

Sagar Lonial, MD, provides insight on mechanisms of resistance to CAR T-cell therapies, and the panel shares unmet needs and future directions for the treatment of multiple myeloma.